Lv2
130 积分 2024-03-02 加入
Combination locoregional and systemic therapies in hepatocellular carcinoma
1天前
已完结
Immune-mediated colitis associated with ocrelizumab: A new safety risk
25天前
已完结
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
3个月前
已完结
Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
3个月前
已完结
Multi-omics reveals the impact of cancer-associated fibroblasts on the prognosis and treatment response of adult diffuse highest-grade gliomas
7个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
7个月前
已完结
Mitapivat for sickle cell disease and thalassemia
皖公网安备34019202002308
